首页> 美国卫生研究院文献>Infection and Drug Resistance >Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients

【2h】

Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients

机译：补充恩替卡韦或改用聚乙二醇化干扰素可改善HBe抗原阴性慢性乙型肝炎患者的HBsAg清除率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and aimsChronic hepatitis B (CHB) patients rarely achieve hepatitis B surface antigen (HBsAg) loss with nucleosideucleotide analog therapy.

机译：背景与目的慢性乙型肝炎（CHB）患者很少通过核苷/核苷酸类似物疗法实现乙型肝炎表面抗原（HBsAg）的丢失。

著录项

期刊名称 Infection and Drug Resistance
作者
Lei Yan; Chuanwu Zhu; Jing Li; Liwen Chen; Yezhou Ding; Zhujun Cao; Kehui Liu; Lanyi Lin; Weiliang Tang; Qing Xie; Yumin Xu; Shisan Bao; Hui Wang;
展开▼
作者单位

展开▼
年(卷),期 2018(11),-1
年度 2018
页码 2001–2009
总页数 9
原文格式 PDF
正文语种
中图分类药学 ;
关键词
chronic hepatitis B HBsAg PEG-IFN entecavir switch-to add-on;

机译：慢性乙型肝炎;HBsAg;PEG-IFN;恩替卡韦;转用;附加;

相似文献

外文文献
中文文献
专利

1. Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients [J] . Lei Yan, Chuanwu Zhu, Jing Li, Infection and Drug Resistance . 2018 ,第9期

机译：补充恩替卡韦或改用聚乙二醇化干扰素可改善HBe抗原阴性慢性乙型肝炎患者的HBsAg清除率
2. Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study [J] . Tatsukawa Yumiko, Tsuge Masataka, Kawakami Yoshiiku, Antiviral therapy . 2018 ,第8期

机译：在HBE-抗原阴性慢性乙型肝炎核苷/核苷酸类核苷酸的核苷/核苷酸类似物疗法中，减少乙型肝炎表面抗原对核苷/核苷酸类似物疗法：试验研究
3. Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study (vol 23, pg 639, 2018) [J] . Tatsukawa Yumiko, Tsuge Masataka, Kawakami Yoshiiku, Antiviral therapy . 2018 ,第8期

机译：在HBE-抗原阴性慢性乙型肝炎患者中序贯对核苷酸与加入聚乙二醇化干扰素的肝炎表面抗原对核苷/核苷酸类似物疗法的减少：试验研究（第23卷，PG 639,2018）
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study [O] . Feng-Ping Wu, Ying Yang, Mei Li, 2020

机译：聚乙二醇化干扰素相对于连续性乙肝表面抗原≤1500 IU / mL的中国慢性乙型肝炎患者可提高乙肝表面抗原清除率
7. Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study [O] . Yumiko Tatsukawa, Masataka Tsuge, Yoshiiku Kawakami, 2018

机译：在HBE-抗原阴性慢性乙型肝炎患者中序贯对核苷酸与加入聚乙二醇化干扰素对核苷酸/核苷酸类似物治疗的肝炎表面抗原的减少：试验研究

Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients

摘要

著录项

相似文献

相关主题

期刊订阅